MELISSA BEANS: Open Payments
NPI 1205384989 · WARRINGTON, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,269 in 41 payments from 20 companies in 2025. Trend: 2023 $3,559 · 2024 $3,475 · 2025 $1,269
Food & beverage: $1,269
| Company | Payments | Amount |
|---|---|---|
| Alexion Pharmaceuticals, Inc. | 2 | $149 |
| CSL Behring | 2 | $146 |
| ABBVIE INC. | 7 | $145 |
| E.R. Squibb & Sons, L.L.C. | 1 | $120 |
| Novartis Pharmaceuticals Corporation | 6 | $117 |
| UCB, Inc. | 4 | $92 |
| EMD Serono, Inc. | 3 | $79 |
| TG Therapeutics, Inc. | 2 | $64 |
| ACADIA Pharmaceuticals Inc | 2 | $52 |
| PFIZER INC. | 2 | $41 |
Products named: ULTOMIRIS, Hizentra, ZEPOSIA, KESIMPTA, Zilbrysq, BRIUMVI, UBRELVY, VYALEV.
Industry payments across PA — which companies pay providers there.
